Creative Spirit Counseling, Pllc | |
1535 42nd St S Suite 400 Fargo ND 58103-3383 | |
(701) 715-8567 | |
(701) 540-0098 |
Full Name | Creative Spirit Counseling, Pllc |
---|---|
Speciality | Social Worker |
Location | 1535 42nd St S, Fargo, North Dakota |
Authorized Official Name and Position | Emily M Jones (MANAGING MEMBER/CLINICAL) |
Authorized Official Contact | 7017158567 |
Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
Mailing Address | Practice Location Address |
---|---|
Creative Spirit Counseling, Pllc 1535 42nd St S Suite 400 Fargo ND 58103-3383 Ph: (701) 715-8567 | Creative Spirit Counseling, Pllc 1535 42nd St S Suite 400 Fargo ND 58103-3383 Ph: (701) 715-8567 |
NPI Number | 1134779176 |
---|---|
Provider Enumeration Date | 09/11/2019 |
Last Update Date | 01/23/2024 |
Certification Date | 02/15/2021 |
Medicare PECOS PAC ID | 8527492966 |
---|---|
Medicare Enrollment ID | O20191218001439 |
News Archive
House Republican leaders believe their leverage in forcing budget cuts to Medicare, Medicaid and other programs will be greater in the next battles.
Dr. David Adams, a dermatologist at Penn State Hershey, doesn't buy recent news reports that poison ivy has become stronger and more prevalent lately.
Tessera Inc., a Seattle-based biomedical company is, in collaboration with Dr. Robert Getzenberg, Director of the Brady Urological Research Institute at Johns Hopkins University, developing blood tests for both prostate and colon cancer and expects to commence clinical trials on EPCA (Early Prostate Cancer Antigen), its first blood test for prostate cancer, before the end of this year.
A new study explores one troubling manifestation of long COVID, which is the cognitive impairment that follows clinical resolution of COVID-19.
› Verified 8 days ago
Identifier | Type | State | Issuer |
---|---|---|---|
1134779176 | NPI | - | NPPES |
1478422 | Medicaid | ND |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
1041C0700X | Social Worker - Clinical | (* (Not Available)) | Primary |
Provider Name | Emily M Jones |
---|---|
Provider Type | Practitioner - Clinical Social Worker |
Provider Identifiers | NPI Number: 1184142945 PECOS PAC ID: 9436583879 Enrollment ID: I20191218001508 |
News Archive
House Republican leaders believe their leverage in forcing budget cuts to Medicare, Medicaid and other programs will be greater in the next battles.
Dr. David Adams, a dermatologist at Penn State Hershey, doesn't buy recent news reports that poison ivy has become stronger and more prevalent lately.
Tessera Inc., a Seattle-based biomedical company is, in collaboration with Dr. Robert Getzenberg, Director of the Brady Urological Research Institute at Johns Hopkins University, developing blood tests for both prostate and colon cancer and expects to commence clinical trials on EPCA (Early Prostate Cancer Antigen), its first blood test for prostate cancer, before the end of this year.
A new study explores one troubling manifestation of long COVID, which is the cognitive impairment that follows clinical resolution of COVID-19.
› Verified 8 days ago
Provider Name | Kaitlyn R Jacobsen |
---|---|
Provider Type | Practitioner - Clinical Social Worker |
Provider Identifiers | NPI Number: 1962043026 PECOS PAC ID: 8022442276 Enrollment ID: I20200117000741 |
News Archive
House Republican leaders believe their leverage in forcing budget cuts to Medicare, Medicaid and other programs will be greater in the next battles.
Dr. David Adams, a dermatologist at Penn State Hershey, doesn't buy recent news reports that poison ivy has become stronger and more prevalent lately.
Tessera Inc., a Seattle-based biomedical company is, in collaboration with Dr. Robert Getzenberg, Director of the Brady Urological Research Institute at Johns Hopkins University, developing blood tests for both prostate and colon cancer and expects to commence clinical trials on EPCA (Early Prostate Cancer Antigen), its first blood test for prostate cancer, before the end of this year.
A new study explores one troubling manifestation of long COVID, which is the cognitive impairment that follows clinical resolution of COVID-19.
› Verified 8 days ago
Provider Name | Hannah M. Ritteman |
---|---|
Provider Type | Practitioner - Clinical Social Worker |
Provider Identifiers | NPI Number: 1982048351 PECOS PAC ID: 6901224054 Enrollment ID: I20200922001524 |
News Archive
House Republican leaders believe their leverage in forcing budget cuts to Medicare, Medicaid and other programs will be greater in the next battles.
Dr. David Adams, a dermatologist at Penn State Hershey, doesn't buy recent news reports that poison ivy has become stronger and more prevalent lately.
Tessera Inc., a Seattle-based biomedical company is, in collaboration with Dr. Robert Getzenberg, Director of the Brady Urological Research Institute at Johns Hopkins University, developing blood tests for both prostate and colon cancer and expects to commence clinical trials on EPCA (Early Prostate Cancer Antigen), its first blood test for prostate cancer, before the end of this year.
A new study explores one troubling manifestation of long COVID, which is the cognitive impairment that follows clinical resolution of COVID-19.
› Verified 8 days ago
Provider Name | Shannon Pfau |
---|---|
Provider Type | Practitioner - Occupational Therapist In Private Practice |
Provider Identifiers | NPI Number: 1023553849 PECOS PAC ID: 6204235377 Enrollment ID: I20210521000331 |
News Archive
House Republican leaders believe their leverage in forcing budget cuts to Medicare, Medicaid and other programs will be greater in the next battles.
Dr. David Adams, a dermatologist at Penn State Hershey, doesn't buy recent news reports that poison ivy has become stronger and more prevalent lately.
Tessera Inc., a Seattle-based biomedical company is, in collaboration with Dr. Robert Getzenberg, Director of the Brady Urological Research Institute at Johns Hopkins University, developing blood tests for both prostate and colon cancer and expects to commence clinical trials on EPCA (Early Prostate Cancer Antigen), its first blood test for prostate cancer, before the end of this year.
A new study explores one troubling manifestation of long COVID, which is the cognitive impairment that follows clinical resolution of COVID-19.
› Verified 8 days ago
Provider Name | Lisa M Burger |
---|---|
Provider Type | Practitioner - Clinical Social Worker |
Provider Identifiers | NPI Number: 1619510617 PECOS PAC ID: 6507235983 Enrollment ID: I20221206002949 |
News Archive
House Republican leaders believe their leverage in forcing budget cuts to Medicare, Medicaid and other programs will be greater in the next battles.
Dr. David Adams, a dermatologist at Penn State Hershey, doesn't buy recent news reports that poison ivy has become stronger and more prevalent lately.
Tessera Inc., a Seattle-based biomedical company is, in collaboration with Dr. Robert Getzenberg, Director of the Brady Urological Research Institute at Johns Hopkins University, developing blood tests for both prostate and colon cancer and expects to commence clinical trials on EPCA (Early Prostate Cancer Antigen), its first blood test for prostate cancer, before the end of this year.
A new study explores one troubling manifestation of long COVID, which is the cognitive impairment that follows clinical resolution of COVID-19.
› Verified 8 days ago
Provider Name | Lynae S Hemming |
---|---|
Provider Type | Practitioner - Mental Health Counselor |
Provider Identifiers | NPI Number: 1598259814 PECOS PAC ID: 5092102905 Enrollment ID: I20240111002639 |
News Archive
House Republican leaders believe their leverage in forcing budget cuts to Medicare, Medicaid and other programs will be greater in the next battles.
Dr. David Adams, a dermatologist at Penn State Hershey, doesn't buy recent news reports that poison ivy has become stronger and more prevalent lately.
Tessera Inc., a Seattle-based biomedical company is, in collaboration with Dr. Robert Getzenberg, Director of the Brady Urological Research Institute at Johns Hopkins University, developing blood tests for both prostate and colon cancer and expects to commence clinical trials on EPCA (Early Prostate Cancer Antigen), its first blood test for prostate cancer, before the end of this year.
A new study explores one troubling manifestation of long COVID, which is the cognitive impairment that follows clinical resolution of COVID-19.
› Verified 8 days ago
News Archive
House Republican leaders believe their leverage in forcing budget cuts to Medicare, Medicaid and other programs will be greater in the next battles.
Dr. David Adams, a dermatologist at Penn State Hershey, doesn't buy recent news reports that poison ivy has become stronger and more prevalent lately.
Tessera Inc., a Seattle-based biomedical company is, in collaboration with Dr. Robert Getzenberg, Director of the Brady Urological Research Institute at Johns Hopkins University, developing blood tests for both prostate and colon cancer and expects to commence clinical trials on EPCA (Early Prostate Cancer Antigen), its first blood test for prostate cancer, before the end of this year.
A new study explores one troubling manifestation of long COVID, which is the cognitive impairment that follows clinical resolution of COVID-19.
› Verified 8 days ago
Insight Counseling Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 1330 Page Dr S Ste 202a, Fargo, ND 58103 Phone: 701-367-5985 Fax: 701-353-2080 | |
Child And Family Therapy Associates Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 1121 Westrac Dr S Ste 204, Fargo, ND 58103 Phone: 701-893-3419 Fax: 701-356-8801 | |
Fraser, Ltd. Mental Health Clinic Medicare: Medicare Enrolled Practice Location: 2902 University Dr S, Fargo, ND 58103 Phone: 701-232-3301 Fax: 701-237-5775 | |
Sanford Neuroscience Clinic Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 700 1st Ave S, Fargo, ND 58103 Phone: 701-234-4036 Fax: 701-234-4134 | |
Shanti Wellness Pllc Mental Health Clinic Medicare: Medicare Enrolled Practice Location: 3481 University Dr S Ste 104, Fargo, ND 58104 Phone: 701-353-9238 Fax: 701-205-1221 | |
Path Minnesota, Inc. Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 1202 Westrac Dr S Ste 400, Fargo, ND 58103 Phone: 701-280-9545 Fax: 701-451-9473 | |
Forest River Counseling Pc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 3523 45th St S, Fargo, ND 58104 Phone: 701-793-5400 |